샘플 요청 목록

 카트 문의
시장보고서
상품코드
1795369

세계의 안정동위원소 표지 생체분자 시장

Stable Isotope Labeled Biomolecules
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 169 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

안정동위원소 표지 생체분자 세계 시장은 2030년까지 5억 1,700만 달러에 달할 전망

2024년에 3억 7,110만 달러로 추정되는 안정동위원소 표지 생체분자 세계 시장은 2030년에는 5억 1,700만 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 5.7%로 성장할 것으로 예측됩니다. D 표지 생체분자는 이 보고서에서 분석한 부문 중 하나로 CAGR은 5.4%를 기록하며 분석 기간 종료시에는 3억 800만 달러에 달할 것으로 예측됩니다. 15N 표지 생체분자 부문의 성장률은 분석 기간 동안 CAGR 6.6%로 추정됩니다.

미국 시장은 9,760만 달러로 추정, 중국은 CAGR 5.5%로 성장 예측

미국의 안정동위원소 표지 생체분자 시장은 2024년에 9,760만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 8,290만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 5.5%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 5.0%와 4.9%로 예측됩니다. 유럽에서는 독일이 CAGR 4.6%로 성장할 것으로 예측됩니다.

세계의 안정동위원소 표지 생체분자 시장 - 주요 동향과 촉진요인 정리

연구용 안정동위원소 표지 생체분자의 성장을 주도하는 것은?

안정동위원소 표지 생체분자는 13C, 15N, 2H 표지 아미노산, 뉴클레오티드, 지질, 대사산물 등 단백질체학, 대사체학, 약동학, 추적자 연구에서 중요한 도구입니다. 질량 분석 분석, 동위원소 희석 정량, MRI 영상제, 세포 추적 실험, 대사 플럭스 분석에 사용됩니다. 주요 최종사용자는 학술 연구소, 제약 연구 개발, 바이오 제조 QC, 석유화학 시험 등입니다.

정확한 정량, 경로 매핑, 품질 보증과 같은 복잡한 워크플로는 동위원소 종류와 표지 부위에 따라 맞춤화된 고순도 표지 표준 물질에 대한 접근에 의존합니다. 제조업체는 세포배양, 내부 표준화, 이미징 애플리케이션을 위해 분자를 맞춤화하여 세포배양에 통합하고, 내부 표준화합니다. LC-MS/MS 및 단편 분석에서 분석 장비와 소프트웨어의 발전으로 인해 강력한 동위원소 표준 물질에 대한 수요가 증가하고 있습니다.

생산 및 맞춤형 플랫폼이 가용성을 높이고 있는가?

기업들은 고순도 동위원소를 생산하기 위해 생합성(표지된 전구체를 이용한 미생물 발효), 화학합성, 효소적 생물전환의 규모를 확대하고 있습니다. 새로운 플랫폼은 부위별 표지 및 다중 표지 조합(듀얼 13C-15N 등)을 지원하여 세밀한 대사 분석을 가능하게 합니다. 플래시 크로마토그래피와 HPLC를 이용한 자동 정제 시스템을 통해 처리량을 향상시키고 비용을 절감할 수 있습니다.

디지털 주문 포털과 샘플 배송 추적을 통해 제약사의 타임라인에 맞춘 신속한 맞춤형 배치를 통해 납기를 최적화할 수 있습니다. 약물 대사 시험 및 미생물 플럭스 평가용으로 조정된 다중 동위원소 키트는 CRO 및 바이오 제조업체의 활용을 촉진하고 있습니다.

왜 연구자들은 이러한 도구들을 분야별로 통합하는 것일까?

정량생물학자와 약리학자들은 절대농도 측정, 클리어런스 프로파일링, 약물간 상호작용 연구에 동위원소 표지 표준물질을 활용하고 있습니다. 시스템 생물학자들은 표지된 전구체를 이용하여 천연물의 생합성 경로를 추적하고 있습니다. 작물 및 환경 연구자들은 토양-식물 시스템에서 흡수 및 전환을 추적하기 위해 표지된 대사 산물을 사용합니다. 임상 영양학 연구에서 안정동위원소 액체 추적자는 비침습적으로 흡수와 대사의 운명을 추적합니다. 규제 기관은 QC 실험실에서 분석 검증 및 배치 릴리스 테스트를 위해 라벨이 부착된 내부 표준 물질을 필요로 합니다.

안정동위원소 표지 생체분자 시장의 성장 원동력은?

안정동위원소 표지 생체분자 시장의 성장 원동력은 조사 정확도, 생산 확장성, 다학제적 채택과 관련된 몇 가지 요인에 기인합니다. 발효 및 화학 표지법의 발전으로 비용이 절감되고 복잡한 동위원소의 가용성이 확대되고 있습니다. 단백질체학, 대사체학, 의약품 파이프라인에 대한 전 세계적인 투자 증가가 고품질 표준물질에 대한 수요를 뒷받침하고 있습니다. 맞춤형 단기 합성 및 턴키 표준 키트는 CRO, 바이오제약, 학계의 타임라인을 충족시킬 수 있습니다. 의약품 및 식품 안전 분석에서 정확한 정량에 대한 규제적 기대도 보급을 촉진하고 있습니다. 또한, 장비 공급업체와 동위원소 공급업체 간의 파트너십을 통해 표지 표준물질과 시료 전처리, 분석, 소프트웨어를 결합한 통합 워크플로우가 가능해져 결과 도출 시간과 연구 품질을 가속화할 수 있습니다.

부문

유형(D 표지 생체분자, 15N 표지 생체분자, 13C 표지 생체분자), 최종사용자(과학 연구, 의료)

조사 대상 기업 사례

  • Alsachim
  • BOC Sciences
  • Cambridge Isotope Laboratories
  • CDN Isotopes
  • Cerilliant Corporation
  • Entegris(IsoSciences)
  • Eurisotop
  • Ionetix
  • IsoFlex
  • IsoLife BV
  • JSC Isotope
  • LGC Standards
  • Lumiprobe
  • Medical Isotopes, Inc.
  • Merck KGaA(Sigma-Aldrich)
  • NIST
  • Nordion(Canada), Inc.
  • Omicron Biochemicals, Inc.
  • PerkinElmer, Inc.
  • Silantes

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSM 25.08.28

Global Stable Isotope Labeled Biomolecules Market to Reach US$517.0 Million by 2030

The global market for Stable Isotope Labeled Biomolecules estimated at US$371.1 Million in the year 2024, is expected to reach US$517.0 Million by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. D Labeled Biomolecules, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$308.0 Million by the end of the analysis period. Growth in the 15N Labeled Biomolecules segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$97.6 Million While China is Forecast to Grow at 5.5% CAGR

The Stable Isotope Labeled Biomolecules market in the U.S. is estimated at US$97.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$82.9 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.0% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Stable Isotope Labeled Biomolecules Market - Key Trends & Drivers Summarized

What’s Driving Growth in Stable Isotope Labeled Biomolecules for Research?

Stable isotope labeled biomolecules-such as ¹³C, ¹5N, ²H labeled amino acids, nucleotides, lipids, and metabolites-are critical tools in proteomics, metabolomics, pharmacokinetics, and tracer studies. Used in mass spectrometry assays, isotope dilution quantification, MRI imaging agents, cell tracing experiments, and metabolic flux analysis. Major end-users include academic labs, pharma R&D, biomanufacturing QC, and petrochemical testing.

Complex workflows-accurate quantification, pathway mapping, quality assurance-depend on access to high-purity labeled standards customized by isotope type and labeling sites. Manufacturers tailor molecules for cell-culture incorporation, internal standardization, and imaging applications. Analytical instrumentation and software advancements in LC-MS/MS and fragment analysis have elevated demand for robust isotopic standards.

Are Production & Customization Platforms Advancing Availability?

Companies are scaling biosynthesis (microbial fermentation with labeled precursors), chemical synthesis, and enzymatic biotransformations to produce high-purity isotopologues. New platforms support site-specific labeling and multiple-label combinations (e.g., dual ¹³C-¹5N), enabling fine-grained metabolic analysis. Automated purification systems using flash chromatography and HPLC increase throughput and reduce costs.

Turn-around optimization-rapid custom batches for pharma timelines-is supported by digital ordering portals and sample delivery tracking. Multi-isotope kits tailored for drug metabolism studies and microbial flux assessments are boosting usage in CROs and biomanufacturers.

Why Are Researchers Integrating These Tools Across Disciplines?

Quantitative biologists and pharmacologists rely on isotope-labeled standards for absolute concentration measurement, clearance profiling, and drug-drug interaction studies. Systems biologists track natural-product biosynthesis pathways using labeled precursors. Crop and environmental researchers use labeled metabolites to trace uptake and transformation in soil-plant systems. Stable isotope liquid tracers in clinical nutritional studies supply non-invasive tracking of absorption and metabolic fate. Regulatory bodies require labeled internal standards for assay validation and batch release tests in QC labs.

What’s Powering the Growth in the Stable Isotope Labeled Biomolecules Market?

The growth in the stable isotope labeled biomolecules market is driven by several factors related to research precision, production scalability, and interdisciplinary adoption. Advances in fermentation and chemical-labeling methods are reducing costs and expanding availability of complex isotopologues. Increasing global investment in proteomics, metabolomics, and drug pipelines supports demand for high-quality standards. Customized, short-run synthesis and turnkey standard kits meet CRO, biopharma, and academic timelines. Regulatory expectations for precise quantification in drug and food safety assays support widespread adoption. Additionally, partnerships between instrument vendors and isotope suppliers enable integrated workflows-combining labeled standards with sample prep, analytics, and software-accelerating time-to-result and research quality.

SCOPE OF STUDY:

The report analyzes the Stable Isotope Labeled Biomolecules market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (D Labeled Biomolecules, 15N Labeled Biomolecules, 13C Labeled Biomolecules); End-Use (Scientific Research End-Use, Medical End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 37 Featured) -

  • Alsachim
  • BOC Sciences
  • Cambridge Isotope Laboratories
  • CDN Isotopes
  • Cerilliant Corporation
  • Entegris (IsoSciences)
  • Eurisotop
  • Ionetix
  • IsoFlex
  • IsoLife BV
  • JSC Isotope
  • LGC Standards
  • Lumiprobe
  • Medical Isotopes, Inc.
  • Merck KGaA (Sigma-Aldrich)
  • NIST
  • Nordion (Canada), Inc.
  • Omicron Biochemicals, Inc.
  • PerkinElmer, Inc.
  • Silantes

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Stable Isotope Labeled Biomolecules - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growth in Proteomics and Metabolomics Research Drives Demand for Labeled Biomolecules
    • Rising Adoption of Mass Spectrometry in Life Sciences Propels Use of Stable Isotopes
    • Personalized Medicine and Targeted Drug Development Expand Addressable Research Applications
    • Regulatory Emphasis on Quantitative Bioanalysis Strengthens Business Case for Labeled Standards
    • Increase in Biopharma R&D Budgets Accelerates Demand for High-Purity Stable Isotope Compounds
    • Expansion of Clinical Diagnostics and Biomarker Discovery Spurs Usage in Preclinical Studies
    • Growth in Academic-Industry Collaborations Facilitates Commercial Availability of Custom Molecules
    • Technological Advancements in Labeling Techniques Improve Accuracy and Yield
    • Adoption of Isotope Dilution Techniques in Environmental and Food Testing Broadens Market Scope
    • Outsourcing Trends in Drug Discovery Boost Demand for Third-Party Stable Isotope Services
    • Rising Complexity of Biotherapeutics Drives Requirement for Multi-Isotopic Labeling
    • Globalization of CROs and CDMOs Expands Supply Chain for Labeled Biomolecule Manufacturing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Stable Isotope Labeled Biomolecules Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Stable Isotope Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Stable Isotope Labeled Biomolecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for D Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for D Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for D Labeled Biomolecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for 15N Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for 15N Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for 15N Labeled Biomolecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for 13C Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for 13C Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for 13C Labeled Biomolecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Scientific Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Scientific Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Scientific Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Medical End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Medical End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Medical End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Stable Isotope Labeled Biomolecules by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Stable Isotope Labeled Biomolecules by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
  • REST OF WORLD
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제